These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32607520)

  • 1. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    medRxiv; 2020 Jun; ():. PubMed ID: 32607520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Tamariz L; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    Lancet Healthy Longev; 2021 Jan; 2(1):e34-e41. PubMed ID: 33521772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
    Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
    Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
    Lally MA; Tsoukas P; Halladay CW; O'Neill E; Gravenstein S; Rudolph JL
    J Am Med Dir Assoc; 2021 Jan; 22(1):193-198. PubMed ID: 33232684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study.
    Bramante CT; Johnson SG; Garcia V; Evans MD; Harper J; Wilkins KJ; Huling JD; Mehta H; Alexander C; Tronieri J; Hong S; Kahkoska A; Alamgir J; Koraishy F; Hartman K; Yang K; Abrahamsen T; Stürmer T; Buse JB;
    PLoS One; 2022; 17(11):e0271574. PubMed ID: 36395143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection.
    Ong AN; Tan CC; Cañete MT; Lim BA; Robles J
    J ASEAN Fed Endocr Soc; 2021; 36(2):133-141. PubMed ID: 34966196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
    Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
    Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis.
    Teague TT; Payne SR; Kelly BT; Dempsey TM; McCoy RG; Sangaralingham LR; Limper AH
    Respir Res; 2022 Apr; 23(1):91. PubMed ID: 35410255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy.
    Monda VM; Voci C; Strollo F; Passaro A; Greco S; Monesi M; Bigoni R; Porcellati F; Piani D; Satta E; Gentile S
    Diabetes Ther; 2023 Dec; 14(12):2127-2142. PubMed ID: 37801224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease.
    Tignanelli CJ; Bramante CT; Dutta N; Tamariz L; Usher MG; Ikramuddin S
    Surg Obes Relat Dis; 2021 Oct; 17(10):1780-1786. PubMed ID: 34326020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus.
    Li W; Li J; Wei Q; McCowen K; Xiong W; Liu J; Jiang W; Thomas R; Hepokoski M; He M; Shyy J; Malhotra A; Xiong N
    Res Sq; 2021 Mar; ():. PubMed ID: 33791691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.
    Zhou J; Zhang G; Chang C; Chou OHI; Lee S; Leung KSK; Wong WT; Liu T; Wai AKC; Cheng SH; Zhang Q; Tse G
    Acta Diabetol; 2022 May; 59(5):697-709. PubMed ID: 35112189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the patterns of use of medications with mortality of COVID-19 infection: a hospital-based observational study.
    Wallace AW; Cirillo PM; Ryan JC; Krigbaum NY; Badathala A; Cohn BA
    BMJ Open; 2021 Dec; 11(12):e050051. PubMed ID: 34972763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy.
    Raju A; Shetty S; Cai B; D'Souza AO
    J Manag Care Spec Pharm; 2016 May; 22(5):483-92. PubMed ID: 27123911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.